| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-11 | Mashal Robert Director | Purchase | +25,000 | +12.50%225,000 | $4.73 | $118,250 | View SEC filing | |
| 2026-04-21 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | -50,000 | -73.53%18,000 | $5.02 | $251,000 | View SEC filing | |
| 2026-04-21 | Wentworth Kerry CHIEF REGULATORY OFFICER | Sale | -36,750 | -40.95%53,000 | $5.01 | $184,279 | View SEC filing | |
| 2026-04-08 | Wentworth Kerry CHIEF REGULATORY OFFICER | Sale | -200,000 | -79.05%53,000 | $4.52 | $903,560 | View SEC filing | |
| 2025-12-03 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | -150,000 | -89.29%18,000 | $7.82 | $1,173,255 | View SEC filing | |
| 2025-11-26 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | -20,000 | -35.71%18,000 | $7.75 | $155,000 | View SEC filing | |
| 2025-11-24 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | -20,000 | -52.63%18,000 | $7.00 | $140,074 | View SEC filing | |
| 2025-11-24 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale | -369,051 | -100.00%0 | $7.23 | $2,667,132 | View SEC filing | |
| 2025-11-21 | Hanley David C. CHIEF TECHNICAL OPERATIONS | Sale | -200,000 | -89.29%24,000 | $7.14 | $1,427,680 | View SEC filing | |
| 2025-11-19 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | -30,000 | -40.00%18,000 | $4.93 | $148,028 | View SEC filing | |
| 2025-10-29 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale | -100,000 | -100.00%0 | $5.02 | $502,460 | View SEC filing | |
| 2025-06-18 | Markel Stacy CHIEF PEOPLE OFFICER | Purchase | +10,000 | +51.04%29,591 | $1.71 | $17,100 | View SEC filing | |
| 2025-06-18 | Sauvage Philippe Chief Financial Officer | Purchase | +7,300 | +280.55%9,902 | $1.81 | $13,216 | View SEC filing | |
| 2025-06-18 | Sjogren Colleen Chief Commercial Officer | Purchase | +50,000 | +161.29%81,000 | $1.81 | $90,350 | View SEC filing | |
| 2025-06-18 | Wentworth Kerry CHIEF REGULATORY OFFICER | Purchase | +50,000 | +100.00%50,000 | $1.79 | $89,740 | View SEC filing | |
| 2025-06-18 | Hung David PRESIDENT AND CEO | Purchase | +500,000 | +0.85%59,281,054 | $1.79 | $893,500 | View SEC filing | |
| 2025-05-06 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | -20,000 | -62.50%12,000 | $2.50 | $50,024 | View SEC filing | |
| 2025-04-08 | Hung David PRESIDENT AND CEO | Purchase | +500,000 | +0.86%58,781,054 | $1.64 | $820,220 | View SEC filing | |
| 2025-04-03 | Mashal Robert Director | Purchase | +100,000 | +100.00%200,000 | $1.67 | $166,985 | View SEC filing | |
| 2024-11-13 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Sale | -56,361 | -1.44%3,866,228 | $2.89 | $162,883 | View SEC filing | |
| 2024-10-10 | Mashal Robert Director | Purchase | +100,000 | +100.00%100,000 | $2.20 | $220,000 | View SEC filing | |
| 2024-06-26 | Cui Xiangmin Director | Purchase | +277,895 | +12.78%2,453,131 | $2.97 | $825,348 | View SEC filing | |
| 2024-06-25 | Cui Xiangmin Director | Purchase | +500,000 | +29.85%2,175,236 | $2.98 | $1,492,385 | View SEC filing | |
| 2024-06-13 | BLICKENSTAFF KIM D Director | Purchase | +172,189 | +100.00%172,189 | $2.90 | $500,089 | View SEC filing | |
| 2023-09-22 | NODELMAN OLEG Director | Purchase | +5,313,100 | +72.17%12,674,775 | $1.26 | $6,692,265 | View SEC filing |
1-25 of 37
